Addition of romiplostim to conditioning prior to HSCT allows chemotherapy reduction while maintaining engraftment levels
C. Matthias Wilk
, Larisa V. Kovtonyuk
, Markus G. Manz
Research output: Contribution to journal › Article › peer-review
1Scopus
citations
Fingerprint
Dive into the research topics of 'Addition of romiplostim to conditioning prior to HSCT allows chemotherapy reduction while maintaining engraftment levels'. Together they form a unique fingerprint.